OVID
Ovid Therapeutics Inc.
$1.29
+$0.08(+6.61%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$81.06M
Volume
1.34M
52W Range
$0.24 - $1.47
Target Price
$2.88
EPS Estimates Overview
| Current Quarter | $-0.14 | Next Quarter | $-0.13 |
| Current Year | $-0.49 | Next Year | $-0.58 |
| QoQ Growth | +7.1% | YoY Growth | -18.4% |
| 3Y EPS CAGR | -30.2% | Target Price | $2.88 |
| Consensus | Buy | Upside | +123.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OVID | $1.29 | +6.6% | 1.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |